about
Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritisMethotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trialsAssociation of rheumatoid arthritis susceptibility gene with lipid profiles in patients with rheumatoid arthritisDoes the "Hispanic paradox" occur in rheumatoid arthritis? Survival data from a multiethnic cohort.Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds.Multi-dimensional health assessment questionnaire in China: reliability, validity and clinical value in patients with rheumatoid arthritisAge at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study.Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patientsMerging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice.Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significanceTRAF1/C5 polymorphism is not associated with increased mortality in rheumatoid arthritis: two large longitudinal studies.A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass.Identification of undiagnosed inflammatory arthritis in a community health fair screenA genome-wide homozygosity association study identifies runs of homozygosity associated with rheumatoid arthritis in the human major histocompatibility complex.Mortality trends in patients with early rheumatoid arthritis over 20 years: results from the Norfolk Arthritis Register.Comparison of the efficacy and safety of two starting dosages of prednisolone in early active rheumatoid arthritis (CORRA): study protocol for a randomized controlled trial.No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics RegisterRheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts.TNF-α antagonist use and risk of hospitalization for infection in a national cohort of veterans with rheumatoid arthritisBiomarkers predicting a need for intensive treatment in patients with early arthritisReasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspectiveAssociations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry.Safety and clinical efficacy of golimumab in the treatment of arthritides.Strain differences in alveolar neutrophil infiltration and macrophage phenotypes in an acute lung inflammation modelIncreased risk of depression in patients with rheumatoid arthritis: a seven-year population-based cohort study.Poor physical function, pain and limited exercise: risk factors for premature mortality in the range of smoking or hypertension, identified on a simple patient self-report questionnaire for usual care.Mortality in Rheumatoid Arthritis (RA): factors associated with recording RA on death certificates.Preserved skeletal muscle protein anabolic response to acute exercise and protein intake in well-treated rheumatoid arthritis patientsDyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapyA pilot study on short term heart rate variability & its correlation with disease activity in Indian patients with rheumatoid arthritis.Co-morbidity in patients with early rheumatoid arthritis - inflammation mattersRisk and predictors of cardiovascular disease in psoriasis: a population-based study.Biologics Prescribing for Rheumatoid Arthritis in Older Patients: A Single-Center Retrospective Cross-Sectional Study.The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases.Effects of Biologic Agents in Patients with Rheumatoid Arthritis and Amyloidosis Treated with Hemodialysis.Alterations to the middle cerebral artery of the hypertensive-arthritic rat model potentiates intracerebral hemorrhage.Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study.Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy.Circulating miRNA-125b is a potential biomarker predicting response to rituximab in rheumatoid arthritisMortality in patients with rheumatoid arthritis: a 15-year prospective cohort study
P2860
Q26852081-23463E8B-E8D0-4B7C-8BFE-9BECC65A2B20Q28085725-2B992A71-C77E-42D8-A2C7-5F68207E5F89Q28386085-6349BDDE-962D-48E0-91BA-6B218487A8D7Q30715768-BB1B90D2-4F45-4A1D-B189-3E1E35869803Q33591510-35F1FBED-C997-4F70-86A1-C16629E548A1Q33645362-A7FB297B-2F94-43FC-AF3D-461B47FE0027Q33765844-9FFF9F37-5B56-4FA5-BC92-019751622E12Q33865776-C9B146E0-CED3-41E7-8560-C35E2484E6B6Q33873068-8A65F48E-F4B4-4266-8FB2-0FE1DEAA58CEQ33893385-0F272EFB-588F-4DD4-9B28-174C0D6E2097Q33923265-2BB3B7A7-5AEB-4412-A491-C5A1F1D36BD6Q33923332-6436EC5B-3ECB-415A-83F2-2F75E679F426Q34035693-3FC46CC0-5A6E-483A-B1EB-1C305005E6E3Q34247086-C0F08943-B573-4404-BF02-E52F1FD0EDFFQ34481954-552B6C18-9A9B-41DC-90F8-1E50FFE8EAFBQ34587411-BD593523-409C-4321-B261-A8FC68E7DB87Q34699641-05F0B16C-A495-4851-A29E-EE3D042BEE15Q34746646-E8D708E2-949B-490B-937C-A9BD62D1BF28Q34792330-61AF6754-DB67-40F9-A4C0-303DE708ABA8Q34982012-6B078CC5-9BDB-4F86-BAA8-D13E6A6C65D5Q35024257-CD6B6D35-5EF5-4F23-9D76-F74C6E93E5A4Q35025293-A9F5C05A-6C00-4715-A1C9-7407057123F0Q35026454-D59969EC-6267-495D-A767-E93704C2333BQ35136753-FD96B7CB-08C4-410E-A2D4-3D12D3897910Q35152581-5A758D00-66C0-47E0-9724-89CC6B1C838DQ35320040-B0BB220C-2F75-4EAD-BB14-CC59E9267923Q35800079-D5724476-101F-4EFC-934C-B7092E087E2AQ36093378-BDC44DDE-FE50-4422-8317-76856A7780D9Q36113215-F80B226F-5B57-4BE9-A375-5A71582A4FBBQ36449974-9060D53C-EECC-4C48-B87A-027DB99DBC41Q36513993-A4DF9345-96A9-4F4F-BE08-8C3509800EBFQ36515160-67A95876-5ED4-46FC-9BD3-429B8A1D757CQ36943015-977FEDDF-3B97-4C17-9430-279953059A60Q37027093-E82F0D91-0B31-4407-8D5D-FBBDF1D1B753Q37383148-3EE7280C-D8F6-4429-A39C-71F407BE0A4DQ37402723-BBFE6F50-E640-468B-A613-F3DBA1EEA7E9Q37442945-617A9B58-8182-41A0-BABB-5404BF8C886EQ37473766-B4A887D1-DC10-4F04-9816-893FA5029AF3Q37693747-A072869B-8E35-4B6E-A263-480A3194042DQ37709979-488019CA-679A-4BD6-8EB9-E53E8D8731F9
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Mortality in rheumatoid arthritis: 2008 update.
@ast
Mortality in rheumatoid arthritis: 2008 update.
@en
Mortality in rheumatoid arthritis: 2008 update.
@nl
type
label
Mortality in rheumatoid arthritis: 2008 update.
@ast
Mortality in rheumatoid arthritis: 2008 update.
@en
Mortality in rheumatoid arthritis: 2008 update.
@nl
prefLabel
Mortality in rheumatoid arthritis: 2008 update.
@ast
Mortality in rheumatoid arthritis: 2008 update.
@en
Mortality in rheumatoid arthritis: 2008 update.
@nl
P2093
P1476
Mortality in rheumatoid arthritis: 2008 update
@en
P2093
P304
P433
5 Suppl 51
P577
2008-09-01T00:00:00Z